Algernon Pharmaceuticals (TSE:AGN) has released an update.
Algernon Pharmaceuticals has extended the expiration date of nearly 4.75 million outstanding warrants by six months, now set to expire on May 5, 2025. This decision, which affects a significant portion held by company insiders, is subject to Canadian Securities Exchange approval but has already been granted certain exemptions.
For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.
